Breaking News

Amcor Offers To Buy Alcan Units

Amcor has offered to acquire parts of Alcan Packaging for $2.0 billion from Rio Tinto.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Amcor has offered to acquire parts of Alcan Packaging for $2.0 billion from Rio Tinto. The Alcan Packaging businesses it has agreed to acquire include: Alcan Packaging Global Pharmaceuticals, Alcan Packaging Food Europe, Alcan Packaging Food Asia and Alcan Packaging Global Tobacco.

The combined company will be one of the world’s leading packaging companies with significant breadth of expertise, products and services, according to an Amcor statement. As of June 2009, Amcor generated $7.8 billion in sales from operations in 34 countries and has 226 sites worldwide, with approximately 21,000 employees. The parts of Alcan Packaging that Amcor has offered to acquire would add approximately $4.1 billion in sales and 14,000 employees across 80 plants in 28 countries.

The proposed acquisition will also support Amcor’s stated objective of growing in its strategic business areas of flexible packaging and folding cartons packaging.

Amcor’s managing director and chief executive officer, Ken MacKenzie, remarked, “We believe that this acquisition will bring customers of both Amcor and Alcan Packaging even greater value through broader offerings and enhanced customer service. Critically, beyond the hard assets, the combined company will draw on the best people from both organisations to drive these improvements.”

Mr. MacKenzie added, “This acquisition is a clear fit with our strategic growth plans, building greater shareholder value by expanding our business whilst obtaining the economies of scale that comes with an opportunity such as this. We are committed to becoming a leader in the global packaging industry.”

The acquisition is subject to regulatory approvals as well as consultation with European Works Councils. Closing of the acquisition is not expected to occur for several months. Until this time, both Amcor and Alcan Packaging will continue to operate as separately run companies.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters